BUTETHAMATE CITRATE

Butethamate citrate is a centrally acting antitussive reducing cough frequency. Side effects include mild sedation, dizziness, and dry mouth.

SKU: af8a2239c5a3 Category: Tag:

Product Description


Mechanism of action

Butethamate is a central cough suppressant acting via non-opioid pathways in the medullary cough centre. It reduces cough reflex sensitivity without depressing respiration. Its mechanism includes modulation of central sensory integration and mild anticholinergic activity.

Benefits and advantages

Used in cough-suppression studies, central-respiratory control research, non-opioid antitussive modelling, vagus-mediated reflex investigations and pharmacodynamic comparison with opioid antitussives.

Side effects and risks

Risks include mild sedation, dizziness, dry mouth and GI upset. Handle with CNS-active safety protocols.

Datasheet


Molecular Formula

C16H25NO2

Molecular Weight

263.37 g/mol

CAS Number

14007-64-8

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Butetamate; Butethamate; 14007-64-8; Butetamato; Butetamatum

IUPAC/Chemical Name

2-(diethylamino)ethyl 2-phenylbutanoate

InChl Key

CKWHSYRZDLWQFV-UHFFFAOYSA-N

InChl Code

InChI=1S/C16H25NO2/c1-4-15(14-10-8-7-9-11-14)16(18)19-13-12-17(5-2)6-3/h7-11,15H,4-6,12-13H2,1-3H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/27368;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download